Skip to main content
. 2019 Mar 18;18:1534735419833795. doi: 10.1177/1534735419833795

Table 1.

The Effect of 5-FU and GMI on Complete Blood Counts.

Group WBC (×103/µL) RBC (×106/µL) HGB (g/dL) HCT (%) MCV (fL) MCH (pg) MCHC (g/dL) PLT (×103/µL)
Control 9.53 ± 1.066 10.27 ± 1.21 15.45 ± 2.03 51.78 ± 7.51 50.3 ± 1.67 15.05 ± 0.98 29.93 ± 1.70 942.5 ± 252.6
5-FU 3.42 ± 1.00** 9.03 ± 0.51 14.58 ± 0.68 45 ± 2.70 49.82 ± 0.36 16.16 ± 0.61 32.44 ± 1.24 416.6 ± 54.2
5-FU + GMI 3.7 ± 0.53** 9.48 ± 2.20 15.675 ± 2.53 47.05 ± 11.46 49.6 ± 0.88 16.6 ± 2.04* 33.5 ± 4.88* 379.5 ± 138.1

Abbreviations: 5-FU, 5-fluorouracil; GMI, Ganoderma microsporum immunomodulatory protein; WBC, white blood cell; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin content; MCHC, mean corpuscular hemoglobin; PLT, platelets.

*

P < .01, **P < .01 versus the control group. Data presented are means ± SD.